Panbela Therapeutics, Inc. (PBLA)
Panbela Therapeutics, Inc. is a biopharmaceutical enterprise currently in clinical development, along with its subsidiaries, dedicated to advancing innovative therapies for cancer patients. The company's therapeutic endeavors primarily target pancreatic disorders, including pancreatitis, pancreatic cancer, and neoadjuvant pancreatic cancer. Beyond pancreatic diseases, they are also exploring treatments for colorectal cancer, ovarian cancer, and various other oncology indications. Their flagship experimental drug, SBP-101, is currently undergoing Phase Ia/Ib clinical trials, specifically intended for individuals diagnosed with metastatic pancreatic ductal adenocarcinoma. Established in 2011, the company, headquartered in Waconia, Minnesota, rebranded from its prior name, Sun BioPharma, Inc., to Panbela Therapeutics, Inc. in December 2020.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Panbela Therapeutics, Inc.
OTC:PBLAHealthcare · Biotechnology
$0.0001
Mkt Cap$485
Float4.85M
O/S4.85M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$25.26M
Total Assets$11.8M
Free Cash Flow-$25.25M
Debt & Equity
Debt 1073%
Total Debt$5.19M
Total Equity-$4.71M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
- 1:20Reverse splitJan 18, 202420 shares → 1
- 1:30Reverse splitJun 1, 202330 shares → 1
- 1:40Reverse splitJan 13, 202340 shares → 1
Balance Sheet Details
Assets$11.8M
Liabilities$16.51M
Accounts Receivable$183K
Accounts Payable$9.94M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.36M | $974K | $1.23M | $700K |
| YoY Growth | - | - | - | - | - | - | - | - | - | 39.3% | -21.0% | 76.2% | - |
| Cost of Revenue | $25.65M | $35.73M | $10.01M | $5.75M | $4.32M | $3.89M | $6.02M | $5.17M | $5.44M | $595K | $558K | $692K | $551K |
| Gross Profit | -$25.65M | -$35.73M | -$10.01M | -$5.75M | -$4.32M | -$3.89M | -$6.02M | -$5.17M | -$5.44M | $762K | $415K | $541K | $149K |
| Gross Margin | - | - | - | - | - | - | - | - | - | 56.1% | 42.7% | 43.9% | 21.3% |
| Research and Development | $20.61M | $28.05M | $5.42M | $2.5M | $2.35M | $1.78M | $2.59M | $2.5M | $2.85M | $2K | $280K | $0 | $0 |
| Selling, General, and Administrative | $5.03M | $6.04M | $4.59M | $3.25M | $1.97M | $2.11M | $3.42M | $2.66M | $2.59M | $837K | $330K | $258K | $254K |
| Other | $0 | $0 | $0 | $0 | $0 | -$508K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $25.65M | $34.09M | $10.01M | $5.75M | $4.32M | $3.84M | $6.02M | $5.17M | $5.44M | $837K | $610K | $258K | $254K |
| Operating Income (EBIT) | -$51.29M | -$34.09M | -$10.01M | -$5.75M | -$4.32M | -$3.89M | -$6.02M | -$5.17M | -$5.44M | -$75K | -$194K | $283K | -$105K |
| Operating Margin | - | - | - | - | - | - | - | - | - | -5.6% | -20.0% | 22.9% | -14.9% |
| Interest Expense | -$317K | $288K | $11K | $17K | $2.19M | $1.81M | $1.62M | $180K | $183K | $36K | $36K | $36K | $34K |
| Interest Income | $123K | $14K | $1K | $17 | $2K | $0 | $1K | $2K | $8K | $4K | $18K | $0 | $0 |
| Other Income (Expense) | $25.84M | -$956K | -$613K | $691K | -$2.29M | -$2.27M | -$4.89M | -$285K | -$564K | -$32K | -$17K | -$35K | -$34K |
| Income Before Tax (EBT) | -$25.45M | -$35.05M | -$10.62M | -$5.06M | -$6.62M | -$6.16M | -$10.91M | -$5.45M | -$5.68M | -$107K | -$212K | $248K | -$138K |
| Income Tax Expense | -$186K | -$116K | -$488K | -$295K | -$415K | -$254K | -$536K | -$341K | -$756K | $121 | $220 | $284 | $115 |
| Net Income | -$25.26M | -$34.93M | -$10.13M | -$4.77M | -$6.2M | -$5.91M | -$10.37M | -$5.11M | -$4.93M | -$107K | -$212K | $247K | -$138K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | -7.9% | -21.8% | 20.1% | -19.8% |
| Supplementary Data | |||||||||||||
| EPS | -232429.55 | -40748.57 | -20773.70 | -14798.10 | -26103.83 | -1519.95 | -3491.75 | -1974.51 | -4203.92 | -892.03 | -1766.84 | 2061.50 | -1152.61 |
| Diluted EPS | -232429.55 | -40748.57 | -20773.70 | -14798.10 | -26103.83 | -1519.95 | -3491.75 | -1974.51 | -4203.92 | -892.03 | -1766.84 | 2061.50 | -1152.61 |
| Weighted Average OS | 3.13M | 857 | 488 | 322 | 238 | 3,885 | 2,971 | 2,589 | 1,172 | 120 | 120 | 120 | 120 |
| EBITDA | -$25.77M | -$18.41M | -$602K | -$4.93M | -$2.34M | -$2.6M | -$7.85M | -$5.25M | -$5.47M | -$75K | -$194K | $289K | -$101K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | -5.6% | -20.0% | 23.5% | -14.5% |
Balance Sheet
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $2.58M | $1.28M | $11.87M | $9.02M | $2.45M | $1.41M | $152K | $438K | $925K | $164K | $59K | $111K | $48K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $18K |
| Cash and Short-Term Investments | $2.58M | $1.28M | $11.87M | $9.02M | $2.45M | $1.41M | $152K | $438K | $925K | $164K | $59K | $111K | $66K |
| Accounts Receivable | $183K | $49K | $321K | $323K | $361K | $332K | $420K | $321K | $733K | $227K | $374K | $225K | $177K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $299K | $443K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $209K | $0 | $0 | $0 |
| Total Current Assets | $3.06M | $1.78M | $12.28M | $9.76M | $3.09M | $1.85M | $767K | $877K | $1.73M | $391K | $433K | $337K | $244K |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $13K | $19K | $16K | $10K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $8.74M | $3.2M | $593K | $56K | $51K | $51K | $0 | $0 | $76K | $3K | $80K | $258K | $0 |
| Total Long-Term Assets | $8.74M | $3.2M | $593K | $56K | $51K | $51K | $0 | $0 | $76K | $16K | $99K | $274K | $10K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $11.8M | $4.98M | $12.87M | $9.81M | $3.14M | $1.9M | $767K | $877K | $1.81M | $407K | $532K | $611K | $254K |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $9.94M | $2.87M | $640K | $554K | $597K | $1.06M | $1.2M | $1.25M | $585K | $297K | $4K | $28K | $39K |
| Short-Term Debt | $1M | $1.65M | $0 | $0 | $116K | $350K | $1.54M | $3.28M | $250K | $567K | $575K | $572K | $560K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | -$350K | -$1.54M | -$3.28M | -$250K | $19K | $33K | $27K | $24K |
| Other Current Liabilities | $516K | $3.32M | $2.02M | $811K | $742K | $216K | $1.44M | $997K | $540K | -$275K | $0 | $0 | $0 |
| Total Current Liabilities | $12.32M | $7.83M | $2.66M | $1.36M | $1.76M | $1.63M | $4.17M | $5.52M | $1.38M | $616K | $664K | $644K | $655K |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $4.19M | $5.19M | $0 | $0 | $0 | $0 | $286K | $0 | $3M | $2K | $6K | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $39K | $0 | -$6K | $0 | $0 |
| Total Long-Term Liabilities | $4.19M | $5.19M | $640K | $0 | $0 | $0 | $286K | $0 | $3.11M | $2K | $6K | $8K | $4K |
| Other Liabilities | $0 | $0 | -$640K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $16.51M | $13.03M | $2.66M | $1.36M | $1.76M | $1.63M | $4.46M | $5.52M | $4.49M | $618K | $670K | $652K | $659K |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $200K | $200K | $200K | $200K |
| Common Stock | $0 | $1K | $13K | $10K | $7K | $5K | $4K | $32K | $30K | $6 | $5 | $86K | $86K |
| Retained Earnings | -$125.5M | -$91.09M | -$56.16M | -$46.03M | -$41.26M | -$35.06M | -$29.15M | -$18.78M | -$13.67M | -$13.99M | -$13.88M | -$13.67M | -$13.92M |
| Comprehensive Income & Other | $745K | $759K | $133K | -$384K | $305K | $283K | -$165K | $76K | $13K | -$105K | -$96K | -$87K | -$81K |
| Other Stockholders' Equity | $120.79M | $83.04M | $66.36M | $54.46M | $42.64M | $35.32M | $25.46M | $14.11M | $10.96M | $13.78M | $13.74M | $13.54M | $13.43M |
| Total Equity | -$4.71M | -$8.05M | $10.21M | $8.45M | $1.39M | $268K | -$3.69M | -$4.64M | -$2.68M | -$211K | -$138K | -$41K | -$405K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $11.8M | $4.98M | $12.87M | $9.81M | $3.14M | $1.9M | $767K | $877K | $1.81M | $407K | $532K | $611K | $254K |
| Supplementary Data | |||||||||||||
| Total Debt | $5.19M | $6.84M | - | $0 | $116K | $350K | $1.82M | $3.28M | $3.33M | $577K | $582K | $586K | $568K |
| Net Debt | $2.62M | $5.56M | -$11.87M | -$9.02M | -$2.33M | -$1.05M | $1.67M | $2.84M | $2.4M | $413K | $523K | $475K | $520K |
Cash Flow Statement
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$25.26M | -$34.93M | -$10.13M | -$4.77M | -$6.2M | -$5.91M | -$10.37M | -$5.11M | -$4.93M | -$107K | -$212K | $247K | -$138K |
| Depreciation & Amortization | $0 | $16.36M | $10.01M | $114K | $2.08M | $1.74M | $1.44M | $28K | $28K | $10K | $9K | $6K | $3K |
| Deferred Income Tax | $0 | $0 | $0 | -$114K | -$2.07M | $0 | $0 | $0 | -$1M | $0 | $0 | -$833 | $0 |
| Stock-Based Compensation | $823K | $1.09M | $1.29M | $1.21M | $1.09M | $1.28M | $1.73M | $902K | $976K | $196 | $600 | $600 | $600 |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | -$132K | $212K | $51K | -$2K | -$31K | $50K | $0 | $426K | -$610K | -$3K | $61K | -$33K | $19K |
| Inventory | $0 | -$212K | -$51K | $2K | $31K | $0 | $0 | $0 | $0 | $76K | $10K | -$291K | -$157K |
| Accounts Payable | $7.06M | $2.25M | $631K | -$747K | $301K | $360K | -$319K | $1.15M | $681K | -$4K | -$24K | -$11K | $26K |
| Other Working Capital | -$7.58M | -$1.69M | $1.51M | $559K | -$113K | $134K | $257K | $620K | -$655K | -$17K | $6K | $3K | $4K |
| Total Working Capital Change | -$647K | $559K | $2.14M | -$188K | $188K | $494K | -$62K | $1.77M | $26K | $52K | $53K | -$332K | -$108K |
| Other Non-Cash Items | -$162K | $1.65M | -$10.01M | -$103K | $2.17M | $4K | $3.86M | $12K | $1M | $34K | $114K | $116K | $170K |
| Net Cash from Operating | -$25.25M | -$15.28M | -$6.7M | -$3.85M | -$2.74M | -$2.39M | -$3.4M | -$2.4M | -$3.9M | -$11K | -$35K | $37K | -$73K |
| Investing Activities | |||||||||||||
| Capital Expenditures | $0 | -$660K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5K | $0 | -$10K |
| Acquisitions | $400K | $4K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $500K | $0 | $0 | $19K | $0 |
| Other Investing Activities | $0 | $0 | -$540K | $0 | $0 | $0 | $0 | $0 | $500 | $125K | -$5K | $833 | $0 |
| Net Cash from Investing | $400K | -$656K | -$540K | $0 | $0 | $0 | $0 | $0 | $500K | $125K | -$5K | $19K | -$10K |
| Financing Activities | |||||||||||||
| Debt Repaid | - | - | - | $757K | $186K | $14K | - | - | - | -$2.39M | $12K | $5K | -$4K |
| Common Stock Issuance | $23.05M | $5.35M | $9.05M | $11.08M | $3.16M | $2.33M | $47K | $1.87M | $1.51M | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | -$10K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $4.75M | $5K | $1.04M | $120K | $0 | $0 | $47K | $42K | $1.16M | -$2.4M | -$12K | $0 | $0 |
| Net Cash from Financing | $26.14M | $5.35M | $10.1M | $10.44M | $3.78M | $3.64M | $3K | $2K | $3K | -$8K | -$12K | $7K | $9K |
| Forex Effect | $0 | -$4K | -$6K | -$17K | -$1K | -$3K | $10K | -$4K | -$7K | -$11 | -$1 | $0 | $0 |
| Net Change in Cash | $1.29M | -$10.58M | $2.85M | $6.57M | $1.04M | $1.25M | -$286K | -$487K | -$729K | $105K | -$52K | $63K | -$74K |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$25.25M | -$15.28M | -$6.7M | -$3.85M | -$2.74M | -$2.39M | -$3.4M | -$2.4M | -$3.9M | -$11K | -$35K | $37K | -$73K |
| Capital Expenditure | $0 | -$660K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5K | $0 | -$10K |
| Free Cash Flow | -$25.25M | -$15.94M | -$6.7M | -$3.85M | -$2.74M | -$2.39M | -$3.4M | -$2.4M | -$3.9M | -$11K | -$41K | $37K | -$83K |
| Cash at Beginning | $1.28M | $11.87M | $9.02M | $2.45M | $1.41M | $152K | $438K | $925K | $1.65M | $59K | $111K | $48K | $122K |
| Cash at End | $2.58M | $1.28M | $11.87M | $9.02M | $2.45M | $1.41M | $152K | $438K | $925K | $164K | $59K | $111K | $48K |